HRSV (B) Post-fusion glycoProtein F0, His Tag (MALS verified) from BIORBYT LTD.
Search, find, compare suppliers for HRSV (B) Post-fusion glycoProtein F0, His Tag (MALS verified) products.
| Edit | |
|---|---|
| Product Name | HRSV (B) Post-fusion glycoProtein F0, His Tag (MALS verified) |
| Description | Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoProtein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion Protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible Protein refolding from the labile prefusion conformation to the stable post-fusion conformation. Both states exhibit epitopes targeted by neutralizing antibodies, and post-fusion RSV F is being developed as a vaccine candidate. Purity 90.00%. MW: 55.2 kDa |
| Size | 50 ug, 500 ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | orb1743018 |
| Price | $740 |
| Order / More Info | HRSV (B) Post-fusion glycoProtein F0, His Tag (MALS verified) from BIORBYT LTD. |
| Product Specific References | n/a |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Profile of BIORBYT LTD.
Return to Products